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therapy (hadron MBRT). The technique is based on the well 
established tissue-sparing effect of arrays of parallel, thin or 
small beams, observed in studies performed with synchrotron 
radiation [1-2]. In parallel, significant tumor growth delay 
was observed in highly aggressive tumors by using interlaced 
irradiations [1-3]. Hadron MBRT combines the advantages of 
MBRT with the high dose conformability and the remarkable 
biological effectiveness of hadrontherapy. This novel strategy 
might guarantee tissue recovery and reduce the side effects 
of radiation in healthy tissues. The main goal of this study 
was to explore this new approach from a dosimetric point of 
view and to verify its technical feasibility at a clinical center 
(HIT, Germany). In particular, carbon and oxygen minibeams 
were studied. 
Materials/methods: Carbon and oxygen minibeams were 
generated through a tungsten multislit collimator with line 
apertures of 700 μm separated by 3500 μm. Scanned 12C and 
16O pencil beams were used to cover a given irradiation field 
size (1x1 cm2) and a spread out Bragg peak (SOBP) region of 
5 cm at 8 cm-depth in water. Radiochromic films (EBT3) were 
placed at several depths in a solid-water slab phantom to 
evaluate dose distributions. Quenching effects of these films 
were also assessed and results were accordingly corrected.  
As a figure of merit, the ratio between the central dose of 
one minibeam (peak dose) and the dose in the middle of two 
consecutive beams (valley dose) was evaluated. This 
magnitude, named peak-to-valley dose ratio (PVDR), is a very 
relevant magnitude in such spatially fractionated techniques 
[4]. 
Results: The measured lateral dose profiles in carbon and 
oxygen MBRT consisted in a pattern of peaks and valleys, 
which prove the technical feasibility of this approach. This 
first dosimetric study showed PVDR values around 10-20 in 
the first centimeters of the phantom. PVDR values 
progressively decrease up to around 5 at 8-cm-depth. These 
PVDR values are in the order of the ones obtained in x-rays 
MBRT, for which biological effectiveness has already been 
proven.  
Conclusions: This is the first exploratory study that 
experimentally proves the technical feasibility of hadron 
MBRT at a clinical center. The PVDR values obtained showed 
the potential of this radiotherapy approach, which might 
allow reducing side effects in the healthy tissues. Animal 
experiments are warranted. 
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Purpose: One strategy to improve the clinical outcome in 
radiotherapy (RT) is to increase the dose effects in the 
tumor. This can be achieved by using specific nanoparticles 
(NP). Numerous studies have shown an enhanced 
effectiveness of tumor cell killing when NP were associated 
to irradiation [1-3]. However, the mechanisms of action are 
not yet clear. In addition to the damage due to a possible 
local dose enhancement, the interaction of NP with essential 
biological macromolecules could lead to changes in the 
cellular function, such as cell arrest at radiosensitive phases 
[4]. These effects, which could be amplified with a 
subsequent irradiation, might increase their anticancer 
effectiveness. Along this line, in this study we used F98 
glioma rat cells as an in vitro model to evaluate the 
intracellular biochemical changes induced by x-ray 
irradiations in combination with Gadolinium NP by using 
Fourier transform infrared microspectroscopy (FTIR). FTIR 
allows in situ chemical structure determination of 
intracellular biomolecules. In addition, this technique has 
significantly contributed to study apoptosis, as well as cell 
cycle and cell death modes.  
Materials/methods: FTIR measurements were performed 
using the internal source of infrared radiation at SESAME 
synchrotron (Jordan). Principal Component Analysis (PCA) 
was performed to show the variances between the different 
sets of spectra.  
Results: Noticeable spectra alterations in the presence or 
absence of NP were detected in the proteins, DNA and lipids 
regions, indicating changes in the cellular function (even in 
the absence of radiation). In particular, biochemical changes 
related to apoptosis were detected. These include a shift 
toward the low wavenumbers in the amide I and II bands, 
relative amplitude changes in the CH2 and CH3 stretching 
modes, along with DNA chromatin condensation indications 
[5]. The figure below shows an example of PCA analysis in 
the DNA region of the infrared spectral range in the presence 
and absence of NP for a dose deposition of 10 Gy.  
 
 
 
Conclusion: This is one of the first research studies 
performed at the Emira laboratory of the SESAME Synchrotron 
(Jordan). This infared work provides new insights on the 
biochemical effects induced by the combination of 
radiotherapy and nanoparticles, for which the full 
mechanisms of interaction are not well known up to now. 
Results will be discussed in relation to cell viability studies. 
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We present the first results obtained with a detector, called 
Large Area Pixelized Detector (LAPD), dedicated to the beam 
ballistic control in the context of hadrontherapy.  
The purpose is to control the ballistics of the beam delivered 
to the patient by in-beam and real time detection of 
secondary particles, emitted during its irradiation. These 
particles could be high energy photons (γ prompt), or charged 
particles like protons, or 511 keV γ from the annihilation of a 
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positron issued from the β+ emitters induced in the patient 
tissues along the beam path. These methods require being 
able to detect with a huge efficiency, and with a minimum 
dead time, these secondary particles emitted when the beam 
hits the patient.  
The LAPD is similar to a conventional Positron Emission 
Tomography camera. The 511 keV γ are detected and the 
reconstructed line of responses allow to measure the β+ 
activity distribution.  Nevertheless, when trying to use γ from 
positron annihilations for the ballistic control in 
hadrontherapy, the large γ prompt background should be 
taken into account and properly rejected. 
This detector is made of two half-rings of 120 channels each 
(figure 1).  
 
 
Figure 4: the LAPD, a PET-like detector dedicated to beam 
ballistic control in hadrontherapy. 
 
Each channel consists of a 13*13*15 mm3 LYSO crystal glued 
to a PMT. The PMT signal is sent to an Analog Sampling 
Module (ASM board). This VME 6U board is based on the DRS4 
chip technology (Switch Capacitor Array) from the Paul 
Sherrer Institute and was specially designed for the LAPD 
detector. This board receives up to 24 differential analog 
input signals, with maximum amplitude of 600 mV, digitized 
by 12 bits - 33 MHz ADC. The sampling rate varies between 1 
and 5 GHz, for a maximum buffer size of 1024 samples. 
The first part of the talk is devoted to the description of the 
detector and its electronics. Then, we describe the various 
trigger strategy, and the on-going upgrade of the VME-based 
acquisition system to a µTCA-based technology. The selection 
of the coincident 511 keV γ is also discussed, and the 
reconstruction using an iterative MLEM algorithm is 
presented. In the last part of the talk, few results from an 
experiment with one third of the detector, using proton and 
carbon ion beams at the Heidelberg Ion-Beam Therapy Center 
in 2014, are also described, and the Coincidence Resolution 
Time and energy resolution are given. First reconstruction 
results, obtained with a phantom filled with a high intensity 
FDG source at the cancer research center of Clermont-
Ferrand in 2015 are also shown.  
This detector is now characterized, and will be installed at 
the Lacassagne hadrontherapy center (Nice, France), on the 
65 MeV line (Medicyc) in December 2015 first, and on the 
future 230 MeV line (S2C2 from IBA) in 2016. The capability 
of this detector and its associated electronics to measure the 
ballistic of the proton beam in real clinical conditions with a 
sufficient precision will be evaluated.  
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Purpose: Ion beams are used for highly precise 
radiotherapy, making an accurate dose deposition in tissue 
crucial. However, this accuracy can be compromised by 
unpredictable changes of the patient. Therefore an online 
monitoring of the beam within the patient is of large 
interest. The main challenge is given by stopping of the 
entire beam inside of the patient. Our group investigates 
the possibility to collect and reconstruct the information 
about the beam extension in the patient by detecting 
light ions emitted from the irradiated object, suggested in 
[1]. Exploiting the directions of secondary ions measured, a 
method for visualization and quantification of the carbon 
ion beam profile in a homogeneous phantom was 
published in [2]. In this contribution, the capability of 
the method to detect inhomogeneities in  otherwise 
homogeneous phantoms is presented. 
Materials & methods: The experiments were performed at 
the Heidelberg Ion Beam Therapy Center  (HIT) in 
Germany. Narrow carbon ion beams of therapy-relevant 
energies, were directed onto homogneneous plastic 
phantoms with a typical head size. Secondary ions emerging 
from the phantom during the irradiation, were detected 
by a Timepix detector [3] developed by the Medipix 
Collaboration at CERN. A multilayered detector, 
consisting of 3 parallel Timepix detectors, was used to 
measure their tracks in 3D. The track distributions acquired 
with a full phantom were compared with cases when 
parts of the phantom were missing at several positions, 
simulating cavities in the body. 
Results: It was found that exploiting the information 
carried by secondary ions enables to visualize cavities in 
the irradiated volume at different positions of the Bragg 
curve. The method was found to be sensitive also to 
cavities situated behind the Bragg peak (in the fragment 
tail). Moreover, a three-dimensional image reconstruction 
based on maximum likelihood expectation maximization 
(MLEM) exploiting the measured secondary particle tracks 
was developed. In the resulting images, air cavities and 
inhomogeneities with density differences down to 0.3 g cm−3 
to the surrounding material are clearly visualized for the first 
time. 
Conclusions: Our experimental results demonstrate that 
this novel imaging modality enables clear visualization of 
down to 1 cm-sized air cavities in head-sized phantoms, 
under clinical irradiation conditions. Therefore we conclude 
that secondary ions, being a by-product of the irradiation, 
are an attractive source of information on the actual beam 
extension in the irradiated body. 
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